Streamex Corp.
STEXFinancial ServicesNASDAQCapital Markets · Last scanned May 30, 2026
Scan Results
Daily timeframeHeadquartered within the financial services sector, Streamex Corp. focuses on Capital Markets services and products. Streamex Corp., a medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States. The $322.2M market capitalization puts STEX squarely in small-cap range for its industry. The company offers the PURE EP platform, which delivers cardiac signal data to electrophysiologists during ablation procedures for the treatment of cardiovascular arrhythmias.
Market Cap
$322.2M
Beta
—
P/E (TTM)
—
P/E (Fwd)
4.58
EPS (TTM)
$-9.78
EPS (Fwd)
$0.33
ROE
-625.2%
ROA
-71.0%
Cash
$30.6M
Total Debt
$0
Free CF
-$10.9M
52W Change
-78.5%
Annual Financials
Cash vs Debt
Streamex Corp. reports $30.6M in cash and $0 in total debt. Free cash flow is running at -$10.9M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -625.2% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has pulled back from $286K (2022) to $0 (2025), a 100% decline worth watching.
Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Streamex Corp.'s trajectory.